← Back to Search

Procedure

Single-arm for Sensorineural Hearing Loss

N/A
Waitlist Available
Research Sponsored by Med-El Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to twelve (12) months post-activation
Awards & highlights

Study Summary

This trial is testing whether a MED-EL cochlear implant can help adults with moderate to profound sensorineural hearing loss who don't get much benefit from hearing aids.

Eligible Conditions
  • Sensorineural Hearing Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to twelve (12 months) post-activation
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to twelve (12 months) post-activation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ear structure
Percent correct words recognition in quiet in implanted ear
Secondary outcome measures
Number and proportion of subjects experiencing device related adverse events
Patient reported improvement in everyday listening conditions
Residual low frequency hearing

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single-armExperimental Treatment1 Intervention
Single-arm, repeated-measures study design with all subjects receiving a MED-EL cochlear implant
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant System
2018
N/A
~50

Find a Location

Who is running the clinical trial?

Med-El CorporationLead Sponsor
23 Previous Clinical Trials
969 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Ear and HearingJournal
The Abbreviated Profile of Hearing Aid Benefit
Cox, Robyn M., and Genevieve C. Alexander. 1995. “The Abbreviated Profile of Hearing Aid Benefit”. Ear and Hearing. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/00003446-199504000-00005.
The LaryngoscopeJournal
MED-EL Combi40+ Cochlear Implantation in Adults
Bassim, Marc K., Emily Buss, Marcia S. Clark, Karen A. Kolln, Carol H. Pillsbury, Harold C. Pillsbury III, and Craig A. Buchman. 2005. “MED-EL Combi40+ Cochlear Implantation in Adults”. The Laryngoscope. Wiley. doi:10.1097/01.mlg.0000171023.72680.95.
Otology & NeurotologyJournal
Results with Cochlear Implantation in Adults with Speech Recognition Scores Exceeding Current Criteria
Amoodi, Hosam A., Paul T. Mick, David B. Shipp, Lendra M. Friesen, Julian M. Nedzelski, Joseph M. Chen, and Vincent Y. W. Lin. 2012. “Results with Cochlear Implantation in Adults with Speech Recognition Scores Exceeding Current Criteria”. Otology & Neurotology. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/mao.0b013e318239e5a1.
The LaryngoscopeJournal
Cochlear Implantation in Patients with Substantial Residual Hearing
Cullen, Robert D., Carol Higgins, Emily Buss, Marcia Clark, Harold C. Pillsbury III, and Craig A. Buchman. 2004. “Cochlear Implantation in Patients with Substantial Residual Hearing”. The Laryngoscope. Wiley. doi:10.1097/01.mlg.0000149462.88327.7f.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top